Pfizer Gets CDC Recommendation for RSV Vaccine
By Ben Glickman
Pfizer has received a recommendation from the U.S. Center for
Disease Control and Prevention for the use of its Respiratory
Syncytial Virus vaccine in pregnant people.
The New York-based pharmaceutcial company said Friday that the
CDC's Advisory Committee on Immunization Practices voted to
recommend Abrysvo for pregnant people from week 32 to week 36.
Pfizer's vaccine, which allows for pregnant people to pass RSV
immunity to their children, was approved by the U.S. Food and Drug
Administration in August.
The recommendation will become official once it is reviewed and
adopted by the CDC's director.
The company said the ACIP had already recommended vaccines to
protect from RSV in older adults, pneumonia in adults and
Write to Ben Glickman at firstname.lastname@example.org
(END) Dow Jones Newswires
September 22, 2023 15:43 ET (19:43 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
から 11 2023 まで 12 2023
から 12 2022 まで 12 2023